Concentration level of latamoxef sodium (LMOX) in prostatic tissue

The concentration of latamoxef sodium (LMOX) in serum and prostatic tissue was evaluated. Thirty seven patients with benign prostatic hypertrophy were given 1 g LMOX intravenously prior to prostatectomy. Prostatic tissue and blood were sampled at 1, 2 or 3 hrs after administration of LMOX. The conce...

Description complète

Détails bibliographiques
Publié dans:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 31(1985), 3 vom: 15. März, Seite 539-43
Auteur principal: Takao, M (Auteur)
Autres auteurs: Matsuzaki, S, Ao, T, Nagakura, K, Fujioka, T, Hata, M, Nakamura, H, Hayakawa, M
Format: Article
Langue:Japanese
Publié: 1985
Accès à la collection:Hinyokika kiyo. Acta urologica Japonica
Sujets:English Abstract Journal Article Anti-Bacterial Agents Moxalactam VUF6C936Z3
Description
Résumé:The concentration of latamoxef sodium (LMOX) in serum and prostatic tissue was evaluated. Thirty seven patients with benign prostatic hypertrophy were given 1 g LMOX intravenously prior to prostatectomy. Prostatic tissue and blood were sampled at 1, 2 or 3 hrs after administration of LMOX. The concentration of LMOX in prostatic tissue was 17.4 +/- 3.4 micrograms/g tissue, 11.1 +/- 1.3 microgram/g tissue and 8.9 +/- 1.3 microgram/g tissue 1, 2 and 3 hrs after injection, respectively (mean +/- S.E.). The penetration ratio of LMOX (concentration in tissue/in serum) to prostate was 30-45%. Therefore, the 80% MIC of LMOX is lower than 8 micrograms/ml for most gram negative bacteria, the results suggest that LMOX is very effective against prostatitis caused by these organisms
Description:Date Completed 06.09.1985
Date Revised 21.11.2013
published: Print
Citation Status MEDLINE
ISSN:0018-1994